IGC Pharma, Inc. (IGC) is a publicly traded Industrials sector company. As of May 20, 2026, IGC trades at $0.29 with a market cap of $28.26M and a P/E ratio of -3.08. IGC moved -1.43% today. Year to date, IGC is -3.09%; over the trailing twelve months it is -9.00%. Its 52-week range spans $0.24 to $0.50. Analyst consensus is buy with an average price target of $5.25. Rallies surfaces IGC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
IGC Pharma, Inc. (IGC) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. IGC moved -1.43% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $0.29 |
| Market Cap | $28.26M |
| P/E Ratio | -3.08 |
| EPS | $-0.09 |
| Dividend Yield | 0.00% |
| 52-Week High | $0.50 |
| 52-Week Low | $0.24 |
| Volume | 642.81K |
| Avg Volume | 0 |
| Revenue (TTM) | $1.27M |
| Net Income | $-7.12M |
| Gross Margin | 48.70% |
1 analysts cover IGC: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $5.25.